APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Immunomodulators

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Immunomodulators Market Outlook and Growth Opportunities 2026

26 December 2025196 pages

Choose your research edition.

Industry ResearchVeterinary Immunomodulators Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Immunomodulators Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Veterinary Immunomodulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Immunomodulators Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Immunomodulators Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Veterinary Immunomodulators market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Immunomodulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Immunomodulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Immunomodulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Immunomodulators market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Immunomodulators market include Biogenesis Bago, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Elanco Animal Health, ImmunoVet Ltd., MSD Animal Health, Phibro Animal Health Corporation, Vetoquinol S.A. and Zoetis, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary Immunomodulators market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Immunomodulators and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Immunomodulators sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Immunomodulators market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Immunomodulators Segment by Company

Biogenesis Bago

Boehringer Ingelheim Animal Health

Ceva Santé Animale

Elanco Animal Health

ImmunoVet Ltd.

MSD Animal Health

Phibro Animal Health Corporation

Vetoquinol S.A.

Zoetis, Inc.

Veterinary Immunomodulators Segment by Type

Injectable

Topical

Oral

Others

Veterinary Immunomodulators Segment by Application

Online Sales

Offline Sales

Veterinary Immunomodulators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Veterinary Immunomodulators status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Veterinary Immunomodulators market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Immunomodulators significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Immunomodulators competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Immunomodulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Immunomodulators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Immunomodulators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Immunomodulators market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Immunomodulators industry.

Chapter 3: Detailed analysis of Veterinary Immunomodulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Veterinary Immunomodulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Veterinary Immunomodulators in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Immunomodulators Industry Trends Table 2. Veterinary Immunomodulators Industry Drivers Table 3. Veterinary Immunomodulators Industry Opportunities and Challenges Table 4. Veterinary Immunomodulators Industry Restraints Table 5. Global Veterinary Immunomodulators Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Immunomodulators Revenue Share by Company (2021-2026) Table 7. Global Veterinary Immunomodulators Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Veterinary Immunomodulators Sales Volume Share by Company (2021-2026) Table 9. Global Veterinary Immunomodulators Average Price (US$/g) of Company (2021-2026) Table 10. Global Veterinary Immunomodulators Company Ranking, (2024-2026) & (USD Million) Table 11. Global Veterinary Immunomodulators Key Company Manufacturing Base & Headquarters Table 12. Global Veterinary Immunomodulators Company, Product Type & Application Table 13. Global Veterinary Immunomodulators Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Immunomodulators by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injectable Table 18. Significant Companies of Topical Table 19. Significant Companies of Oral Table 20. Significant Companies of Others Table 21. Global Veterinary Immunomodulators Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 22. Global Veterinary Immunomodulators Sales Volume by Type (2021-2026) & (Kg) Table 23. Global Veterinary Immunomodulators Sales Volume by Type (2027-2032) & (Kg) Table 24. Global Veterinary Immunomodulators Sales Volume Share by Type (2021-2026) Table 25. Global Veterinary Immunomodulators Sales Volume Share by Type (2027-2032) Table 26. Global Veterinary Immunomodulators Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Veterinary Immunomodulators Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Veterinary Immunomodulators Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Veterinary Immunomodulators Sales Value Share by Type (2021-2026) Table 30. Global Veterinary Immunomodulators Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Online Sales Table 32. Significant Companies of Offline Sales Table 33. Global Veterinary Immunomodulators Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 34. Global Veterinary Immunomodulators Sales Volume by Application (2021-2026) & (Kg) Table 35. Global Veterinary Immunomodulators Sales Volume by Application (2027-2032) & (Kg) Table 36. Global Veterinary Immunomodulators Sales Volume Share by Application (2021-2026) Table 37. Global Veterinary Immunomodulators Sales Volume Share by Application (2027-2032) Table 38. Global Veterinary Immunomodulators Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Veterinary Immunomodulators Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Veterinary Immunomodulators Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Veterinary Immunomodulators Sales Value Share by Application (2021-2026) Table 42. Global Veterinary Immunomodulators Sales Value Share by Application (2027-2032) Table 43. Global Veterinary Immunomodulators Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 44. Global Veterinary Immunomodulators Sales by Region (2021-2026) & (Kg) Table 45. Global Veterinary Immunomodulators Sales Market Share by Region (2021-2026) Table 46. Global Veterinary Immunomodulators Sales by Region (2027-2032) & (Kg) Table 47. Global Veterinary Immunomodulators Sales Market Share by Region (2027-2032) Table 48. Global Veterinary Immunomodulators Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Veterinary Immunomodulators Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Veterinary Immunomodulators Sales Value Share by Region (2021-2026) Table 51. Global Veterinary Immunomodulators Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Veterinary Immunomodulators Sales Value Share by Region (2027-2032) Table 53. Global Veterinary Immunomodulators Market Average Price (US$/g) by Region (2021-2026) Table 54. Global Veterinary Immunomodulators Market Average Price (US$/g) by Region (2027-2032) Table 55. Global Veterinary Immunomodulators Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. Global Veterinary Immunomodulators Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Veterinary Immunomodulators Sales by Country (2021-2026) & (Kg) Table 58. Global Veterinary Immunomodulators Sales Market Share by Country (2021-2026) Table 59. Global Veterinary Immunomodulators Sales by Country (2027-2032) & (Kg) Table 60. Global Veterinary Immunomodulators Sales Market Share by Country (2027-2032) Table 61. Global Veterinary Immunomodulators Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Veterinary Immunomodulators Sales Value Market Share by Country (2021-2026) Table 63. Global Veterinary Immunomodulators Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Veterinary Immunomodulators Sales Value Market Share by Country (2027-2032) Table 65. Biogenesis Bago Company Information Table 66. Biogenesis Bago Business Overview Table 67. Biogenesis Bago Veterinary Immunomodulators Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 68. Biogenesis Bago Veterinary Immunomodulators Product Portfolio Table 69. Biogenesis Bago Recent Development Table 70. Boehringer Ingelheim Animal Health Company Information Table 71. Boehringer Ingelheim Animal Health Business Overview Table 72. Boehringer Ingelheim Animal Health Veterinary Immunomodulators Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 73. Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product Portfolio Table 74. Boehringer Ingelheim Animal Health Recent Development Table 75. Ceva Santé Animale Company Information Table 76. Ceva Santé Animale Business Overview Table 77. Ceva Santé Animale Veterinary Immunomodulators Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 78. Ceva Santé Animale Veterinary Immunomodulators Product Portfolio Table 79. Ceva Santé Animale Recent Development Table 80. Elanco Animal Health Company Information Table 81. Elanco Animal Health Business Overview Table 82. Elanco Animal Health Veterinary Immunomodulators Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 83. Elanco Animal Health Veterinary Immunomodulators Product Portfolio Table 84. Elanco Animal Health Recent Development Table 85. ImmunoVet Ltd. Company Information Table 86. ImmunoVet Ltd. Business Overview Table 87. ImmunoVet Ltd. Veterinary Immunomodulators Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 88. ImmunoVet Ltd. Veterinary Immunomodulators Product Portfolio Table 89. ImmunoVet Ltd. Recent Development Table 90. MSD Animal Health Company Information Table 91. MSD Animal Health Business Overview Table 92. MSD Animal Health Veterinary Immunomodulators Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 93. MSD Animal Health Veterinary Immunomodulators Product Portfolio Table 94. MSD Animal Health Recent Development Table 95. Phibro Animal Health Corporation Company Information Table 96. Phibro Animal Health Corporation Business Overview Table 97. Phibro Animal Health Corporation Veterinary Immunomodulators Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 98. Phibro Animal Health Corporation Veterinary Immunomodulators Product Portfolio Table 99. Phibro Animal Health Corporation Recent Development Table 100. Vetoquinol S.A. Company Information Table 101. Vetoquinol S.A. Business Overview Table 102. Vetoquinol S.A. Veterinary Immunomodulators Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 103. Vetoquinol S.A. Veterinary Immunomodulators Product Portfolio Table 104. Vetoquinol S.A. Recent Development Table 105. Zoetis, Inc. Company Information Table 106. Zoetis, Inc. Business Overview Table 107. Zoetis, Inc. Veterinary Immunomodulators Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 108. Zoetis, Inc. Veterinary Immunomodulators Product Portfolio Table 109. Zoetis, Inc. Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Veterinary Immunomodulators Distributors List Table 113. Veterinary Immunomodulators Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Veterinary Immunomodulators Product Image Figure 2. Global Veterinary Immunomodulators Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Immunomodulators Sales Value (2021-2032) & (US$ Million) Figure 4. Global Veterinary Immunomodulators Sales (2021-2032) & (Kg) Figure 5. Global Veterinary Immunomodulators Sales Average Price (US$/g) & (2021-2032) Figure 6. Global Veterinary Immunomodulators Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injectable Image Figure 10. Topical Image Figure 11. Oral Image Figure 12. Others Image Figure 13. Global Veterinary Immunomodulators Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 14. Global Veterinary Immunomodulators Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Veterinary Immunomodulators Sales Volume Share by Type (2021-2032) Figure 16. Global Veterinary Immunomodulators Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Veterinary Immunomodulators Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Veterinary Immunomodulators Sales Value Share by Type (2021-2032) Figure 19. Online Sales Image Figure 20. Offline Sales Image Figure 21. Global Veterinary Immunomodulators Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 22. Global Veterinary Immunomodulators Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Veterinary Immunomodulators Sales Volume Share by Application (2021-2032) Figure 24. Global Veterinary Immunomodulators Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Veterinary Immunomodulators Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Veterinary Immunomodulators Sales Value Share by Application (2021-2032) Figure 27. Global Veterinary Immunomodulators Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 28. Global Veterinary Immunomodulators Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Veterinary Immunomodulators Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Veterinary Immunomodulators Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Veterinary Immunomodulators Sales Value (2021-2032) & (US$ Million) Figure 32. North America Veterinary Immunomodulators Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Veterinary Immunomodulators Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Veterinary Immunomodulators Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Veterinary Immunomodulators Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Veterinary Immunomodulators Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Veterinary Immunomodulators Sales Value (2021-2032) & (US$ Million) Figure 38. South America Veterinary Immunomodulators Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Veterinary Immunomodulators Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Veterinary Immunomodulators Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Veterinary Immunomodulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Veterinary Immunomodulators Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Veterinary Immunomodulators Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Injectable
  • Topical
  • Oral
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Biogenesis Bago
  • Boehringer Ingelheim Animal Health
  • Ceva Santé Animale
  • Elanco Animal Health
  • ImmunoVet Ltd.
  • MSD Animal Health
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Zoetis, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Immunomodulators Sales Value (2021-2032)
  4. 1.2.2 Global Veterinary Immunomodulators Sales Volume (2021-2032)
  5. 1.2.3 Global Veterinary Immunomodulators Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Veterinary Immunomodulators Market Dynamics
  1. 2.1 Veterinary Immunomodulators Industry Trends
  2. 2.2 Veterinary Immunomodulators Industry Drivers
  3. 2.3 Veterinary Immunomodulators Industry Opportunities and Challenges
  4. 2.4 Veterinary Immunomodulators Industry Restraints
3 Veterinary Immunomodulators Market by Company
  1. 3.1 Global Veterinary Immunomodulators Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Immunomodulators Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Immunomodulators Sales Volume by Company (2021-2026)
  4. 3.4 Global Veterinary Immunomodulators Average Price by Company (2021-2026)
  5. 3.5 Global Veterinary Immunomodulators Company Ranking (2024-2026)
  6. 3.6 Global Veterinary Immunomodulators Company Manufacturing Base and Headquarters
  7. 3.7 Global Veterinary Immunomodulators Company Product Type and Application
  8. 3.8 Global Veterinary Immunomodulators Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Veterinary Immunomodulators Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Veterinary Immunomodulators Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Veterinary Immunomodulators Market by Type
  1. 4.1 Veterinary Immunomodulators Type Introduction
  2. 4.1.1 Injectable
  3. 4.1.2 Topical
  4. 4.1.3 Oral
  5. 4.1.4 Others
  6. 4.2 Global Veterinary Immunomodulators Sales Volume by Type
  7. 4.2.1 Global Veterinary Immunomodulators Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Veterinary Immunomodulators Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Veterinary Immunomodulators Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Veterinary Immunomodulators Sales Value by Type
  11. 4.3.1 Global Veterinary Immunomodulators Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Veterinary Immunomodulators Sales Value by Type (2021-2032)
  13. 4.3.3 Global Veterinary Immunomodulators Sales Value Share by Type (2021-2032)
5 Veterinary Immunomodulators Market by Application
  1. 5.1 Veterinary Immunomodulators Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Veterinary Immunomodulators Sales Volume by Application
  5. 5.2.1 Global Veterinary Immunomodulators Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Veterinary Immunomodulators Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Veterinary Immunomodulators Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Veterinary Immunomodulators Sales Value by Application
  9. 5.3.1 Global Veterinary Immunomodulators Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Veterinary Immunomodulators Sales Value by Application (2021-2032)
  11. 5.3.3 Global Veterinary Immunomodulators Sales Value Share by Application (2021-2032)
6 Veterinary Immunomodulators Regional Sales and Value Analysis
  1. 6.1 Global Veterinary Immunomodulators Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Immunomodulators Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Immunomodulators Sales by Region: 2021-2026
  4. 6.2.2 Global Veterinary Immunomodulators Sales by Region (2027-2032)
  5. 6.3 Global Veterinary Immunomodulators Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Veterinary Immunomodulators Sales Value by Region (2021-2032)
  7. 6.4.1 Global Veterinary Immunomodulators Sales Value by Region: 2021-2026
  8. 6.4.2 Global Veterinary Immunomodulators Sales Value by Region (2027-2032)
  9. 6.5 Global Veterinary Immunomodulators Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Veterinary Immunomodulators Sales Value (2021-2032)
  12. 6.6.2 North America Veterinary Immunomodulators Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Veterinary Immunomodulators Sales Value (2021-2032)
  15. 6.7.2 Europe Veterinary Immunomodulators Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Veterinary Immunomodulators Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Veterinary Immunomodulators Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Veterinary Immunomodulators Sales Value (2021-2032)
  21. 6.9.2 South America Veterinary Immunomodulators Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Veterinary Immunomodulators Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Veterinary Immunomodulators Sales Value Share by Country, 2025 VS 2032
7 Veterinary Immunomodulators Country-level Sales and Value Analysis
  1. 7.1 Global Veterinary Immunomodulators Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Immunomodulators Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Veterinary Immunomodulators Sales by Country (2021-2032)
  4. 7.3.1 Global Veterinary Immunomodulators Sales by Country (2021-2026)
  5. 7.3.2 Global Veterinary Immunomodulators Sales by Country (2027-2032)
  6. 7.4 Global Veterinary Immunomodulators Sales Value by Country (2021-2032)
  7. 7.4.1 Global Veterinary Immunomodulators Sales Value by Country (2021-2026)
  8. 7.4.2 Global Veterinary Immunomodulators Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Veterinary Immunomodulators Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Veterinary Immunomodulators Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Veterinary Immunomodulators Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Biogenesis Bago
  2. 8.1.1 Biogenesis Bago Company Information
  3. 8.1.2 Biogenesis Bago Business Overview
  4. 8.1.3 Biogenesis Bago Veterinary Immunomodulators Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Biogenesis Bago Veterinary Immunomodulators Product Portfolio
  6. 8.1.5 Biogenesis Bago Recent Developments
  7. 8.2 Boehringer Ingelheim Animal Health
  8. 8.2.1 Boehringer Ingelheim Animal Health Company Information
  9. 8.2.2 Boehringer Ingelheim Animal Health Business Overview
  10. 8.2.3 Boehringer Ingelheim Animal Health Veterinary Immunomodulators Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Animal Health Recent Developments
  13. 8.3 Ceva Santé Animale
  14. 8.3.1 Ceva Santé Animale Company Information
  15. 8.3.2 Ceva Santé Animale Business Overview
  16. 8.3.3 Ceva Santé Animale Veterinary Immunomodulators Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ceva Santé Animale Veterinary Immunomodulators Product Portfolio
  18. 8.3.5 Ceva Santé Animale Recent Developments
  19. 8.4 Elanco Animal Health
  20. 8.4.1 Elanco Animal Health Company Information
  21. 8.4.2 Elanco Animal Health Business Overview
  22. 8.4.3 Elanco Animal Health Veterinary Immunomodulators Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Elanco Animal Health Veterinary Immunomodulators Product Portfolio
  24. 8.4.5 Elanco Animal Health Recent Developments
  25. 8.5 ImmunoVet Ltd.
  26. 8.5.1 ImmunoVet Ltd. Company Information
  27. 8.5.2 ImmunoVet Ltd. Business Overview
  28. 8.5.3 ImmunoVet Ltd. Veterinary Immunomodulators Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ImmunoVet Ltd. Veterinary Immunomodulators Product Portfolio
  30. 8.5.5 ImmunoVet Ltd. Recent Developments
  31. 8.6 MSD Animal Health
  32. 8.6.1 MSD Animal Health Company Information
  33. 8.6.2 MSD Animal Health Business Overview
  34. 8.6.3 MSD Animal Health Veterinary Immunomodulators Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 MSD Animal Health Veterinary Immunomodulators Product Portfolio
  36. 8.6.5 MSD Animal Health Recent Developments
  37. 8.7 Phibro Animal Health Corporation
  38. 8.7.1 Phibro Animal Health Corporation Company Information
  39. 8.7.2 Phibro Animal Health Corporation Business Overview
  40. 8.7.3 Phibro Animal Health Corporation Veterinary Immunomodulators Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Phibro Animal Health Corporation Veterinary Immunomodulators Product Portfolio
  42. 8.7.5 Phibro Animal Health Corporation Recent Developments
  43. 8.8 Vetoquinol S.A.
  44. 8.8.1 Vetoquinol S.A. Company Information
  45. 8.8.2 Vetoquinol S.A. Business Overview
  46. 8.8.3 Vetoquinol S.A. Veterinary Immunomodulators Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Vetoquinol S.A. Veterinary Immunomodulators Product Portfolio
  48. 8.8.5 Vetoquinol S.A. Recent Developments
  49. 8.9 Zoetis, Inc.
  50. 8.9.1 Zoetis, Inc. Company Information
  51. 8.9.2 Zoetis, Inc. Business Overview
  52. 8.9.3 Zoetis, Inc. Veterinary Immunomodulators Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Zoetis, Inc. Veterinary Immunomodulators Product Portfolio
  54. 8.9.5 Zoetis, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Immunomodulators Value Chain Analysis
  2. 9.1.1 Veterinary Immunomodulators Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Immunomodulators Sales Mode & Process
  6. 9.2 Veterinary Immunomodulators Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Immunomodulators Distributors
  9. 9.2.3 Veterinary Immunomodulators Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst